Proven Pathways to Global Compliance

Navigated rigorous Notified Body audits to achieve Class III transition for a high-risk orthopedic implant product line within target timelines — ensuring zero market disruption during the MDR transition period.

Optimised software documentation and risk management files to secure FDA clearance in record time with zero requests for additional information — a rare outcome for first-time SaMD submissions.

Developed a centralised QMS and regulatory framework supporting concurrent expansion into Japan (PMDA), Australia (TGA), and Canada (Health Canada) from a single technical documentation set.

Conducted root cause analysis and deep QMS remediation to restore compliance standing and commercial operations for a manufacturer facing critical FDA enforcement action.

Implemented an automated data collection and reporting system for a global diagnostics leader to meet new IVDR requirements, significantly reducing manual reporting burden.

Managed FDA Presubmission interactions to clarify clinical evidence requirements for a breakthrough robotic surgical technology, saving months of potential development rework.

Rationalised testing strategies according to ISO 10993 to significantly reduce submission response times and eliminate redundant testing, saving the client both time and significant testing expenditure.